ARCH Venture Fund VIII Overage, L.P. is 10% Owner at Codiak BioSciences, Inc. (CDAK). They have made 1 open-market trade across 1 company since 2022, most recently 2022-09-13.
CIK 0001617237
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $7.5M since 2022, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CDAK | BUY | 2022-09-13 | 2022-09-15 | $1.50 | $7.5M | -28.0% | -41.3% | -46.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.